Today: 31 May 2026
Quantum computing stocks tumble into weekend: IonQ, Rigetti, D-Wave slide as rate jitters bite

Quantum computing stocks tumble into weekend: IonQ, Rigetti, D-Wave slide as rate jitters bite

NEW YORK, Jan 31, 2026, 13:17 ET — The market has closed.

  • Shares in quantum computing tumbled 7%–9% Friday, slipping well behind the broader tech-heavy Nasdaq.
  • A hotter-than-expected U.S. producer-inflation reading, combined with President Donald Trump’s choice for the next Fed chair, nudged traders toward risk-off sentiment.
  • Coming up: a House vote on federal funding set for Feb. 2, followed by the U.S. jobs report on Feb. 6.

Quantum computing stocks slid heading into the weekend, deepening a steep decline as investors pulled back from speculative tech amid fresh inflation concerns and shifts in U.S. policy cues.

This shift is significant since these are long-duration wagers—firms still developing systems and pushing early access—and their share prices can jump sharply when markets adjust interest rate expectations.

U.S. markets were closed Saturday, leaving the group by Monday’s open moving more as a macro proxy than individual stocks. Investors remain glued to Washington and upcoming data for the next catalyst.

IonQ dropped 7.5% to $39.98 on Friday. Rigetti Computing slid 8.4% to $18.17, while D-Wave Quantum lost 8.6% to close at $21.22. Quantum Computing Inc fell 9.0%, ending the day at $9.27, and Arqit Quantum dropped 8.9% to $20.32.

The broader backdrop was sour. The Nasdaq slipped 0.94% on Friday as traders digested Trump’s pick of former Federal Reserve Governor Kevin Warsh to replace Jerome Powell, mixed earnings from megacaps, and a hotter inflation report. “Markets are calibrating to Trump’s pick of Kevin Warsh … and the outlook for monetary policy,” said Michael Hans, chief investment officer at Citizens Wealth. Reuters

The inflation figure that drew the spotlight was the producer price index (PPI), which tracks prices businesses get for goods and services. It climbed 0.5% in December, well above the 0.2% forecast, Reuters reported, and showed a 3.0% increase year-on-year. Carl Weinberg, chief economist at High Frequency Economics, noted, “This report validates the pivot of the Fed away from labor market risks back toward price stability.” Reuters

Quantum stocks face a tough challenge. Their valuations hinge largely on revenue expected far down the line, so rising rates can swiftly shrink their multiples.

Friday brought no new sector-wide headlines to shake the risk-off mood. The group remained vulnerable after a month marked by sharp, headline-fueled swings.

IonQ, a closely followed name in the sector, is still absorbing the impact of its hardware move this week: it struck a deal to acquire chipmaker SkyWater Technology for roughly $1.8 billion, with the goal of boosting its internal manufacturing capacity.

The outlook can shift quickly. Should rates continue to climb—or if Warsh comes across as less dovish than some expect—smaller, cash-strapped tech firms may see fresh pressure, with dilution risks rising if they have to tap the capital markets.

Washington throws in another wild card. The U.S. government shut down at 12:01 a.m. Eastern on Saturday after Congress missed the funding deadline. The House won’t even consider the package until Monday.

The next major macro event is Friday’s Employment Situation report for January, set for 8:30 a.m. ET on Feb. 6. This snapshot of jobs and wages has the power to swiftly shift rate expectations.

Stock Market Today

  • Nanobiotix Raises €85 Million to Advance JNJ-1900 Cancer Treatment Amid Volatile Stock Rally
    May 30, 2026, 6:54 PM EDT. Nanobiotix (ENXTPA:NANO) completed a €85 million global equity raise to fund the development of JNJ-1900 (NBTXR3), a leading cancer treatment candidate. The financing follows promising Phase 2 trial results in inoperable non-small cell lung cancer, sponsored by Johnson & Johnson. Despite a recent 6.6% dip, shares have soared over 79% year-to-date, closing at €34.04, reflecting high market sensitivity to company developments. The fundraise attracted both European and U.S. investors through ordinary shares, American Depositary Shares, and pre-funded warrants issued near the current share price, suggesting robust demand without steep discounting. Investors will closely monitor Nanobiotix's clinical progress, regulatory updates, and potential partnerships, amid dilution concerns due to the new equity issue.

Latest articles

Realty Income Stock Dips Ahead of Jobs Data; Dividend Investors Eye Rates

Realty Income Stock Dips Ahead of Jobs Data; Dividend Investors Eye Rates

31 May 2026
Realty Income closed Friday at $61.28, down from $62.02 the previous week, as property stocks lagged broader market gains. The company declared a $0.2705 monthly dividend, payable June 15 to shareholders of record May 29. CEO Sumit Roy will present at Nareit’s REITweek on June 3. Investors await the U.S. May jobs report on June 5.
Oklo Stock Higher After Plutonium-Fuel Update

Oklo Stock Higher After Plutonium-Fuel Update

31 May 2026
Oklo shares closed at $66.88 Friday, down 1.78%, after a week of gains sparked by news the U.S. Department of Energy selected the company for advanced talks on using surplus plutonium as reactor fuel. Trading volume reached 27.67 million shares. Oklo reported a first-quarter net loss of $33.1 million and ended March with $2.54 billion in cash and equivalents.
Cameco Stock Is Back in Focus After a Mine Restart — What Investors Watch Next

Cameco Stock Is Back in Focus After a Mine Restart — What Investors Watch Next

31 May 2026
Cameco shares closed Friday at C$154.91 on the TSX, up 7.1% for the week after full production resumed at McArthur River and Key Lake following flood-related disruptions. The company kept its 2026 uranium output guidance unchanged at 19.5–21.5 million pounds. CIBC and National Bank of Canada maintained “Outperform” ratings. Cameco reported Q1 net earnings of C$131 million earlier in May.
GE Aerospace stock price: GE shares rise as 10-K filing flags segment recast and leadership shift
Previous Story

GE Aerospace stock price: GE shares rise as 10-K filing flags segment recast and leadership shift

Tech stocks face a Monday test after Trump taps Warsh for Fed as Big Tech earnings line up
Next Story

Tech stocks face a Monday test after Trump taps Warsh for Fed as Big Tech earnings line up

Go toTop